Product Description
Technical Specification
- Application : Clinic, Hospital
- Medicine Type : Allopathic
- Packaging Type : Box
- Strength : 40000 IU
- Form : Injection
- Manufacturer : Intas Pharmaceuticals Ltd
- Brand : Erykine
- Composition : Recombinant Human Erythropoietin Alfa Injection PFS
- Packaging Size : 1 ml
Potent Therapeutic SolutionErykine 40000 IU Injection delivers a targeted therapeutic dose, formulated for precision and reliability. It is designed for clinical situations where rapid and effective intervention is essential. The medication's potency and liquid form enable healthcare professionals to address specific medical needs seamlessly and with the confidence of standardized dosing.
Secure Storage and HandlingThis product should be stored in a dry place to preserve stability and potency. Correct storage is critical for maintaining the effectiveness of the active ingredients. Healthcare providers and distribution partners are instructed to ensure that the injection is kept under optimal conditions throughout its supply chain journey.
FAQ's of Erykine 40000 IU Injection:
Q: How should Erykine 40000 IU Injection be administered?
A: Erykine 40000 IU Injection must be administered strictly as per the physician's instructions, usually by a trained healthcare professional via injection.
Q: What is the recommended dosage for Erykine 40000 IU Injection?
A: The typical dosage for this medication is 40000 IU; however, the exact dosage and frequency should be determined and supervised by a qualified doctor based on patient requirements.
Q: When is Erykine 40000 IU Injection used?
A: Erykine is administered when rapid intervention with potent dosing is necessary, following the medical condition and a doctor's recommendation.
Q: Where should Erykine 40000 IU Injection be stored?
A: This injection should be stored in a dry place to maintain its efficacy and should be kept away from heat, moisture, or direct sunlight.
Q: What is the process from manufacturing to supply for Erykine 40000 IU Injection in India?
A: Erykine is manufactured and then distributed through multiple channels including dealers, distributors, exporters, importers, retailers, suppliers, traders, and wholesalers to healthcare facilities across India.
Q: What are the main benefits of using Erykine 40000 IU Injection?
A: The primary benefits include rapid absorption, precise dosing at 40000 IU, and efficient therapeutic response under clinical supervision, making it suitable for targeted medical interventions.
Q: How is the usage of Erykine Injection determined?
A: Usage is determined based on the treating physician's guidelines, tailored to the patient's diagnosis and treatment plan to ensure safety and effectiveness.